Nehir Biotech; focuses on microfluidic chips (lab-on-chip), it develops new-generation products in the fields of life sciences, pharmacology, nanotechnology, and chemistry and offers specific solutions for the projects of researchers in these fields.
NehirBT carries out studies on cell analysis, cell&drug interaction, tissue chips (tissue-on-chips), flow chemistry, and point-of-care devices. In 2020, the production of vaccine-drug products in high volumes in lipid nanoparticle (LNP) formulation became successful with the pandemic. With respect to this, NehirBT inspired by the successful microchannel technique of equivalent companies (BIFURCATING MIXING), by developing its own unique design; started to use microfluidic devices in organic particle production and encapsulation formulations.